
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory sync... Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.04 | 9.3023255814 | 0.43 | 0.54 | 0.4278 | 2412796 | 0.49230762 | CS |
4 | 0.11 | 30.5555555556 | 0.36 | 0.54 | 0.36 | 1952462 | 0.44011049 | CS |
12 | -0.031 | -6.1876247505 | 0.501 | 0.5978 | 0.285 | 1830130 | 0.43329259 | CS |
26 | -0.13 | -21.6666666667 | 0.6 | 0.9799 | 0.285 | 1856329 | 0.55996111 | CS |
52 | -0.52 | -52.5252525253 | 0.99 | 1.07 | 0.285 | 2374161 | 0.64814137 | CS |
156 | -3.27 | -87.4331550802 | 3.74 | 4.615 | 0.285 | 2130904 | 1.26162758 | CS |
260 | -2.43 | -83.7931034483 | 2.9 | 24.9 | 0.285 | 6054128 | 6.93261253 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.